Fluorimetric apparatus and method for analysis of body fluid

Claim 2

Fluorimeter for investigation of a sample derived from a body fluid comprising excitation means for producing a beam of irradiating energy of spectral content including energy which is absorbed by such sample to produce fluorescence, presence and/or intensity of which is indicative of a condition under study and detection means including a detector for detecting such radiation characterized in that: 1. the said sample is supported by support means which is essentially transparent to a spectral portion contained within the excitation beam resulting in the said fluorescence; 2. said excitation means emits a beam directed to the underside of the said sample; 3. the said sample has an absorption length of a maximum of one millimeter in the direction of the said excitation beam for the said spectral portion, absorption length being defined as traversal distance within the sample through which incident energy is reduced to 1/eth of its incident value, wherein e is the base of the natural logarithm system; 4. the spectral content of said excitation beam is such that at least 90% of the contained quantum energy absorbed to produce such fluorescence meets the recited absorption length requirement; 5. a detection means is so disposed as to detect fluorescence emanating from the underside of the said sample; 6. both said excitation beam direction and the detection direction defining the direction of the detector relative to the sample are within the solid cone defined by an angle of 45° from a direction normal to the underside of the said sample.

Claim 3

Fluorimeter of claim 1 in which the excitation beam means includes a spectral narrowing means for reducing intensity of spectral content approaching the center wavelength of the said fluorescence.

Claim 4

Fluorimeter of claim 2 in which the spectral narrowing means includes at least one filter for lessening intensity of wavelengths within ten nanometers of the said fluorescence center wavelength.

Claim 5

Fluorimeter of claim 1 in which the said detection means is provided with detection spectral narrowing means for changing the spectral content of energy incident upon the detector.

Claim 6

Fluorimeter of claim 4 in which the said detection spectral narrowing includes at least one element for lessening the intensity of wavelengths which are substantially shorter than the said fluorescence center wavelength.

Claim 7

Fluorimeter of claim 1 including calibration means consisting of a calibration standard having an absorption length for irradiating excitation beam energy as defined in claim 1 and with known concentration of fluorescence centers emitting the said fluorescence which is indicative of a condition under study.

Claim 8

Fluorimeter of claim 6 including a blank standard of absorption characteristics similar to that of the said sample but containing essentially no fluorescence centers emitting the said fluorescence which is indicative of a condition under study.

Claim 9

Fluorimeter of claim 7 including computing means for calibrating the output signal from the said detector and also provided with display means for displaying such calibrated signal.

Claim 10

The fluorimeter of claim 8 in which the said display means provides for a digitized display.

Claim 11

The fluorimeter of claim 1 in which the said sample is chemically unprocessed.

Claim 12

The fluorimeter of claim 10 in which the said sample is fluid.

Claim 13

The fluorimeter of claim 11 in which the said sample is whole blood.

Claim 14

The fluorimeter of claim 12 in which the condition under study results in fluorescence of a porphyrin.

Claim 15

Fluorimeter for investigation of a sample of whole blood comprising excitation means for producing a beam of irradiating energy of spectral content including energy which is absorbed by such sample to produce fluorescence of zinc protoporphyrin, presence and/or intensity of which is indicative of a condition under study and detection means including a detector for detecting such radiation characterized in that: 1. the said sample is supported by support means which is essentially transparent to a spectral portion contained within the excitation beam resulting in the said fluorescence; 2. said excitation means emits a beam directed to the underside of the said sample; 3. the said sample has an absorption length of a maximum of one millimeter in the direction of the said excitation beam for the said spectral portion, absorption length being defined as traversal distance within the sample through which incident energy is reduced to 1/eth of its incident value, wherein e is the base of the natural logarithm system; 4. the spectral content of said excitation beam is such that at least 90% of the contained quantum energy absorbed to produce such fluorescence meets the recited absorption length requirement; 5. a detection means is so disposed as to detect fluorescence emanating from the underside of the said sample; 6. both said excitation beam direction and the detection direction defining the direction of the detector relative to the sample are within the solid cone defined by an angle of 45° from a direction normal to the underside of the said sample.

Claim 16

Fluorimeter for investigation of a sample of whole blood comprising excitation means for producing a beam of irradiating energy of spectral content including energy which is absorbed by such sample to produce fluorescence of zinc protoporphyrin, presence and/or intensity of which is indicative of a condition under study and detection means including a detector for detecting such radiation characterized in that: 1. the said sample is supported by support means which is essentially transparent to a spectral portion contained within the excitation beam resulting in the said fluorescence; 2. said excitation means emits a beam directed to the underside of the said sample; 3. the said sample has an absorption length of a maximum of one millimeter in the direction of the said excitation beam for the said spectral portion, absorption length being defined as traversal distance within the sample through which incident energy is reduced to 1/eth of its incident value, wherein e is the base of the natural logarithm system; 4. the spectral content of said excitation beam is such that at least 90% of the contained quantum energy absorbed to produce such fluorescence meets the recited absorption length requirement; 5. a detection means is so disposed as to detect fluorescence emanating from the underside of the said sample; 6. both said excitation beam direction and the detection direction defining the direction of the detector relative to the sample are within the solid cone defined by an angle of 45° from a direction normal to the underside of the said sample.

Claim 17

The fluorimeter of claim 14 in which the excitation beam has a significant spectral content with a center wavelength of approximately 425 nanometers.

Claim 18

Process for the fluorimetric investigation of a sample of whole blood in accordance with which the said sample is irradiated by a beam of excitation energy of substantial spectral content at a wavelength of about 425 nanometers wherein at least a portion excites fluorescence indicative of presence and/or quantity of zinc protoporphyrin characterized in that: 1. the said excitation beam illuminates the underside of the said sample; 2. fluorescence is detected by a detector positioned under the said sample; 3. both the direction of the excitation beam and the detection are within the solid cone defined by a direction which is 45° to the direction normal to the underside of the said sample; 4. the said sample has an absorption length of a maximum of one millimeter for at least 90% of the spectral content of the said excitation beam which excites fluorescence, and 5. fluorescence is detected by a detector having an electrical output which is readout in the form of a display.

Claim 19

Process for the fluorimetric investigation of a sample of whole blood in accordance with which the said sample is irradiated by a beam of excitation energy of substantial spectral content at a wavelength of about 425 nanometers wherein at least a portion excites fluorescence indicative of presence and/or quantity of zinc protoporphyrin characterized in that: 1. the said excitation beam illuminates the underside of the said sample; 2. fluorescence is detected by a detector positioned under the said sample; 3. both the direction of the excitation beam and the detection are within the solid cone defined by a direction which is 45° to the direction normal to the underside of the said sample; 4. the said sample has an absorption length of a maximum of one millimeter for at least 90% of the spectral content of the said excitation beam which excites fluorescence, and 5. fluorescence is detected by a detector having an electrical output which is readout in the form of a display.

Claim 20

Process for the fluorimetric investigation of a sample derived from a body fluid in accordance with which the said sample is irradiated by a beam of excitation energy of such spectral content that at least a portion excites fluorescence indicative of presence and/or quantity of an agent within such body fluid characterized in that (1) the said excitation beam illuminates the underside of the said sample, (2) fluorescence is detected by a detector positioned under the said sample, (3) both the direction of the excitation beam and the detection are within the solid cone defined by a direction which is 45° to the direction normal to the underside of the said sample, (4) the said sample has an absorption length of a maximum of one millimeter for at least 90% of the spectral content of the said excitation beam which excites fluorescence, and (5) fluorescence is detected by a detector having an electrical output which is read out in the form of a display.

Claim 21

Process for the fluorimetric investigation of a sample derived from a body fluid in accordance with which the said sample is irradiated by a beam of excitation energy of such spectral content that at least a portion excites fluorescence indicative of presence and/or quantity of an agent within such body fluid characterized in that (1) the said excitation beam illuminates the underside of the said sample, (2) fluorescence is detected by a detector positioned under the said sample, (3) both the direction of the excitation beam and the detection are within the solid cone defined by a direction which is 45° to the direction normal to the underside of the said sample, (4) the said sample has an absorption length of a maximum of one millimeter for at least 90% of the spectral content of the said excitation beam which excites fluorescence, and (5) fluorescence is detected by a detector having an electrical output which is read out in the form of a display.

Claim 22

Process of claim 17 in which the said sample is chemically unprocessed body fluid.

Claim 23

Process of claim 18 in which the said sample is whole blood, in which the excitation beam has a substantial spectral content at a wavelength of about 425 nanometers and in that the fluorescence is a porphyrin fluorescence.

Claim 24

Process of claim 17 in which excitation beam path and detection path both include spectral narrowing means for minimizing spectral overlap between the excitation energy illuminating the said sample and the energy detected.

Claim 25

Process of claim 20 in which each said spectral narrowing means includes at least one optical filter.

Claim 26

Process of claim 21 in which each path includes a filter pack, each such pack defining a passband.

Claim 27

Process of claim 22 in which the passband defined for the excitation beam path centers about a wavelength of approximately 425 nanometers.

Claim 28

Process of claim 17 in which the said sample is chemically processed.

Claim 29

Process of claim 24 in which processing includes addition of an addition agent which imparts fluorescence to the said sample.

Claim 30

Process of claim 25 in which processing includes addition of an antigen-containing agent.

Claim 31

Process of claim 26 in which the addition agent includes a fluorescence-labeled antihuman globulin antibody.

Claim 32

Process of claim 27 in which treatment of the said sample comprises a first addition of an antigen-containing agent and a second addition of a fluorescence-labeled antihuman globulin antibody.

Claim 33

Process of claim 28 in which the said antigen-containing agent is a bacterium or virus.